Chronic hepatitis B and IL28B rs12979860 polymorphism: Preliminary study

Molecular Biology Reports

Volumn 40, Issue 11, 2013, Pages 6189-6194

  Kandemir, Özlem ^a   Fidanci, Şenay Balci ^a   Demir, Neslihan ^a   Görür, Ayşegül ^a   Tamer, Lülüfer ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Chronic hepatitis B; IL28 gene polymorphism

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; GENOMIC DNA; INTERLEUKIN 28B; PEGINTERFERON;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; IL28 GENE; MAJOR CLINICAL STUDY; MALE; VIRUS GENE;

ADULT; AGED; ALLELES; ANTIVIRAL AGENTS; FEMALE; GENOTYPE; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84892710772     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2730-0     Document Type: Article

References (19)

1. Sheppard P, Kindsvogel W, Xu W et al (2003) IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 4:63-68
2. Marcello T, Grakoui A, Barba-Spaeth G et al (2006) Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroen-terology 131:1887-1898
3. Ge D, Fellay J, Thompson AJ et al (2009) Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399-401
4. Rauch A, Kutalik Z, Descombes P et al (2010) Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138:1338-1345
5. Suppiah V, Moldovan M, Ahlenstiel G et al (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet 41:1100-1104
6. Tanaka Y, Nishida N, Sugiyama M et al (2009) Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet 41:1105-1109
7. Tillmann HL, Thompson AJ, Patel K et al (2010) A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 139: 1586-1592
8. Martin MP, Qi Y, Goedert JJ et al (2010) IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV Infection. JID 202:1749-1753
9. Ihsak K et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699
10. Peng LJ, Guo JS, Zhang Z, Shi H, Wang J, Wang JY (2012) IL28B rs12979860 polymorphism does not influence outcomes of hepatitis B virus infection. Tissue Antigens 79:302-305
11. Li W, Jiang Y, Jin Q et al (2011) Expression and gene poly-morphisims of interleukin 28B and hepatitis B virus infection in Chinese Han population. Liver Int 31:1118-1126
12. Hong SH, Cho O, Kim K, Shin HJ, Kotenko SV, Park S (2007) Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells. Virus Res 126:245-249
13. Pagliaccetti NE, Chu EN, Bolen CR, Kleinstein SH, Robek MD (2010) Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology 401:197-206
14. Sonneveld MJ, Wong VW, Woltman AM et al (2012) Polymorphisms near IL28B and serologic response to peginterferon in HBeAg-positive patients with chronic hepatitis B. Gastroenter-ology 142:513-520
15. Tillmann HL, Yu MW (2011) IL28B: relevance extended to hepatitis B virus or limited to interferon-based therapies in hepatitis C virus? Liver Int 31:1068-1070
16. Takkenberg B, de Niet A, Benayed R, et al. Association between treatment outcome and rs12979860 polymorphism in HBeAg positive and negative chronic hepatitis B patients treated with Peginterferon alfa-2a (Pegasys) and Adefovir (Hepsera); An interim analysis. Presented as late breaker at the 61st annual meeting of the American Association for the Study of Liver Diseases (AASLD 2010). Boston, October 29-November 2, 2010. http://trs.scivee.tv/node/2651
17. Lütgehetmann M, Bornscheuer T, Volz T et al (2011) Hepatitis B virus limits response of human hepatocytes to interferon-a in chimeric mice. Gastroenterology 140:2074-2083
18. Marcello T, Grakoui A, Barba-Spaeth G et al (2006) Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroen-terology 131:1887-1898
19. Morrow MP, Pankhong P, Laddy DJ et al (2009) Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood 113:5868-5877